Who owns Philips India Limited?

Philips India Limited is a wholly-owned subsidiary of Royal Philips N.V., the Dutch multinational headquartered in Amsterdam, Netherlands. Royal Philips holds 100% of the equity in the Indian subsidiary.

What products does Philips India sell?

Philips India operates in two primary segments: Health Technology (medical imaging systems, patient monitoring, diagnostic ECG, respiratory care, and healthcare IT solutions for hospitals and clinics) and Personal Health (electric shavers, trimmers, oral care products, air purifiers, and mother & child care products for consumers).

When was Philips India Limited incorporated?

Philips India Limited was incorporated in 1930 in Kolkata, West Bengal, making it one of India's oldest registered companies with nearly a century of continuous operations. Its CIN is U31902WB1930PLC006663.

How do I buy Philips India unlisted shares here?

Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.

Who am I actually transacting with?

You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.

How do I pay, and is there a payment gateway?

Payment is by direct bank transfer to Prospire Network Private Limited's published account (CIN U82300UP2025PTC233622), shown to you in-app at the payment step. There is no card gateway and no escrow. Never pay to a personal account or to any account shared over phone, WhatsApp or email — even if the person claims to be from our team.

How long does settlement take?

After you accept an allocation, you have a short window to pay (typically 2 days). Once payment is verified, shares are usually credited to your demat within 2–3 business days, subject to depository timelines and any company-level restrictions. Timeframes are typical, not guaranteed.

There are no separate platform fee lines and no GST on the transfer — the desk's margin is built into the buy/sell price you're quoted. The only statutory add-on on a purchase is stamp duty on the consideration, shown transparently in your cost breakdown.

Is there a minimum ticket size for Philips India?

Minimums vary by company and depend on the lot the desk can source. Raise an enquiry and the desk will confirm the available quantity and the minimum for that name.

What KYC do I need, and do I need a demat account?

You'll share your demat details when you enquire so we can settle directly. Full KYC — PAN and a client-master / demat statement — is required before the transfer step, when shares actually change hands. Yes, you need an active demat account to hold unlisted shares.

Are there lock-ins on unlisted or pre-IPO shares?

Some shares carry statutory or company-imposed lock-ins — for example, a post-listing lock-in on pre-IPO stock — and transfers can be subject to the company's articles or approvals. Where a lock-in applies, we'll flag it before you commit.

How do I sell Philips India shares I already hold?

Raise a sell enquiry with the company, quantity and your target price. The desk confirms a buying price, you transfer your shares into the desk's demat, and once the credit is verified we pay you out by bank transfer to your registered account. The desk never pays out before your shares are received.

Unlisted shares are illiquid, may be hard or impossible to sell, and are not covered by exchange settlement guarantees or investor-protection funds. Pricing is indicative, not live. Read the full Risk Disclosure before you enquire, and invest only what you can afford to lock away.

Philips India Unlisted Share Price | Buy Philips India Pre-IPO Shares — wisefolio

Unlisted shares are illiquid and carry higher risk than listed securities. Prices are indicative, not live. Read the risk disclosure.

Talk to us

Philips India Unlisted Share Price | Buy Philips India Pre-IPO Shares — wisefolio | wisefolio

Investment Thesis

Philips India Limited is a strategically important and historically significant subsidiary of Royal Philips N.V., with nearly 95 years of presence in India. Its pivot to health technology aligns with India's growing healthcare infrastructure needs and the global Philips strategic direction. The company benefits from strong brand equity, Dutch MNC backing, and India's healthcare macro tailwinds. However, as a wholly-owned unlisted subsidiary, investment is not accessible through public markets. Grey market trading is illiquid and does not reflect fundamental valuations. Investors seeking exposure to the India health technology theme should consider the parent Royal Philips N.V. (NYSE: PHG) or listed Indian healthcare companies.

Pros

Wholly-owned subsidiary of Royal Philips N.V. Netherlands, one of the world's largest health technology companies with global R&D, brand equity, and distribution capabilities
One of India's oldest companies, incorporated in 1930, with nearly a century of brand presence and market recognition in India
Philips brand commands strong consumer trust in India across health technology, medical imaging, and personal health segments
Access to Royal Philips' global product innovation pipeline, ensuring a modern and competitive product portfolio in health technology
India's growing healthcare infrastructure investment and increasing health awareness creating significant demand for Philips' health technology products

Cons

Wholly-owned subsidiary status means all strategic decisions, capital allocation, and dividend policies are controlled by the Dutch parent, with no minority shareholder influence
Royal Philips globally has undergone major portfolio restructuring, exiting consumer electronics (TV, audio) and focusing exclusively on health technology — this transition has caused operational disruptions in India
No ISIN publicly available, reflecting very limited grey market trading activity in shares
Global Philips has faced significant challenges including Respironics ventilator recall (2021) affecting its medical devices division, with reputational spillover to all Philips entities
Products sold primarily through independent distributors in India limits direct control over sales experience and market penetration

Business Segments

Health Technology (Professional Healthcare)

Supplies hospitals, clinics, and diagnostic centres with medical imaging systems (X-ray, ultrasound, MRI), patient monitoring systems, diagnostic ECG, and healthcare IT solutions

Personal Health (Consumer Products)

Consumer-facing products including electric shavers, trimmers, hair care, oral care (Sonicare), air purifiers, and mother & child care products sold through retail and e-commerce channels

Revenue Model

Philips India generates revenue through: (1) sale of professional health technology equipment (medical imaging, monitoring) to hospitals, diagnostic chains, and government health programmes; (2) sale of personal health consumer products through independent distributors, modern retail, and e-commerce platforms; and (3) after-sales service, maintenance contracts, and spare parts for installed medical equipment in India.

Detailed Analysis

Growth outlookExpansion plans, industry tailwinds & headwinds14

Growth Plans

India's government healthcare infrastructure spending (Ayushman Bharat, PM-ABHIM) driving institutional demand for Philips medical imaging and monitoring equipment

Rising Indian middle class spending on personal health and wellness products

Royal Philips' global R&D pipeline delivering new health technology innovations for Indian hospitals

India's medical device import substitution policies potentially creating manufacturing opportunities for established players

Recent Developments

Respironics ventilator recall — global impact

Royal Philips issued one of the largest medical device recalls in history for its Respironics sleep therapy and ventilation devices, affecting millions of devices globally due to potential foam degradation risks. While primarily a global issue, this had reputational implications for Philips India's medical devices business and required significant management attention.

2021-06

Strategic refocus on health technology

Philips India continued its transition from a broad consumer electronics company to a focused health technology company, aligned with Royal Philips' global strategy. This included rationalising the consumer product portfolio and deepening investments in professional healthcare solutions for Indian hospitals and diagnostic chains.

2022-03

Healthcare infrastructure demand in India

India's significant public health infrastructure investment under programmes like Ayushman Bharat and PM-ABHIM creates growing demand for medical imaging, diagnostics, and monitoring equipment from established players like Philips India.

Comparable Companies

CompanyTypeTickerMkt Cap

GE Healthcare Technologies Inc.ListedGEHC (NASDAQ)~USD 38 billion

Siemens Healthineers AGListedSHL (Frankfurt)~EUR 45 billion

Royal Philips N.V.ListedPHG (NYSE) / PHIA (Euronext)~EUR 8-10 billion

GE Healthcare Technologies Inc.Listed

GEHC (NASDAQ) · ~USD 38 billion

Frequently Asked Questions

Philips India Limited is the Indian subsidiary of Royal Philips N.V. (Netherlands), one of the world's largest health technology companies. Incorporated in Kolkata in 1930, it is one of India's oldest companies. Philips India operates in health technology (medical imaging, monitoring, diagnostics) and personal health (grooming, oral care, mother and child care) segments, selling primarily through independent distributors across India.

About Philips India

Philips India Limited is one of India's oldest and most recognized multinational corporations, incorporated in 1930 as a subsidiary of Koninklijke Philips N.V. (Royal Philips), headquartered in Eindhoven, Netherlands. With CIN U31902WB1930PLC006663, the company is registered in Kolkata, West Bengal — reflecting its historical roots in India's colonial-era industrial development. For nearly a century, Philips India has been synonymous with innovation in consumer electronics, lighting, and healthcare technology in India. The company was delisted from the Bombay Stock Exchange on 16 February 2004 following a complete takeover by Philips Electronics NV (now Koninklijke Philips), transforming it from a listed company to a fully owned subsidiary operating as an unlisted entity. Philips India currently operates with three key business divisions: Health Systems, Personal Health, and Innovation Services. The Health Systems division manufactures and markets medical imaging equipment, patient monitoring systems, clinical informatics solutions, and other healthcare technology products. The Personal Health division covers a broad range of consumer products including electric shavers, hair care devices, air purifiers, and kitchen appliances. The Innovation Services division represents Philips' R&D and innovation center in India. India has become a strategic hub for Philips globally — the company has significant R&D operations in Pune (Philips Innovation Campus) developing global healthcare technology solutions. This positions Philips India beyond just a sales subsidiary into a value-adding R&D contributor to the global Philips ecosystem. With authorized capital of ₹112 Crore and paid-up capital of ₹57.5 Crore, Philips India has substantial equity backing from its Dutch parent. The company employs thousands of people across its manufacturing, R&D, sales, and service operations. Philips India's century-long presence reflects a deep commitment to the Indian market. The Philips brand carries strong recognition and trust among Indian consumers and healthcare professionals, representing a significant intangible asset.

Key Milestones

Common questions about unlisted shares

How do I buy Philips India unlisted shares here?
Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.
Who am I actually transacting with?
You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.
How do I pay, and is there a payment gateway?

Philips India Limited

How settlement works

Get price alerts for Philips India Limited

Discuss Philips India

Other ways to invest